| (INR) | Dec 2017 | Y/Y change |
|---|---|---|
| Revenue | 745.51M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MANGALAM.NS returned -66.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.6% |
| 1 year | -66.2% |
| 5 years | -78.9% |
| 10 years | -81.7% |
| All-time high | ₹330.20 (Nov 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in MANGALAM.NS would be worth today ›No. Mangalam Drugs & Organics Limited has not paid a dividend in the past 12 months.
Mangalam Drugs & Organics Limited is part of the Healthcare sector.
Mangalam Drugs & Organics Limited has a market cap of 481.81M INR, based on the latest quote.